# OnCo record bcb-214 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bcb-214/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bcb-214" ;
  schema:name "BCB-214"@en ;
  schema:description "BCB-214 is an experimental CAR T cell therapy from BrainChild Bio, at a stage the company does not state for glioblastoma and diffuse midline glioma."@en ;
  schema:url <https://onco.cc/drugs/bcb-214/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.brainchildbio.com/pipeline>, <https://www.brainchildbio.com/pipeline> ;
  onco:tag "pipeline" ;
  onco:modality "CAR T cell therapy (triple-targeting)" ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/b7h3/> ;
  onco:companies <https://onco.cc/companies/brainchild-bio/> .